00000cam 2200000zi 4500 9.965454 CaOODSP 20260925080639 m o d f cr cn||||||||| 250826s2025 onca obs f000 0 eng d CaOODSP eng rda CaOODSP eng fre n-cn--- y1y2 H82-67/2025-PDF Zhang, Yvonne, author. Pressures behind the rising costs in Canadian private drug plans pre- and post- COVID-19 pandemic : 2018-2023 = Pressions à l'origine de l'augmentation des coûts des régimes privés d'assurance-médicaments au Canada avant et après la pandémie de COVID-19 : 2018-2023 / Yvonne Zhang. Pressions à l'origine de l'augmentation des coûts des régimes privés d'assurance-médicaments au Canada avant et après la pandémie de COVID-19 : 2018-2023 [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025] 1 online resource (1 page) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier "NPDUIS, National Prescription Drug Utilization Information System." Includes bibliographical references. "Private drug plans play an important role in the Canadian healthcare system, and costs are a major concern for plan sponsors. This study explores the key cost pressures for private drug plans, differentiating between short-term and long-term effects, and highlighting the impact of the COVID-19 pandemic"--Objective. Text in English and French. Drugs Prices Canada Statistics. Pharmaceutical services insurance Canada Statistics. Statistics lcgft Canada. Patented Medicine Prices Review Board, issuing body. Pressures behind the rising costs in Canadian private drug plans pre- and post- COVID-19 pandemic : fre (CaOODSP)9.966241 PDF 524 KB https://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-67-2025.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/rising-costs-poster2025.html